| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;73:17-28
© 2002 The Society of Thoracic Surgeons
a Section of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, Connecticut, USA
b School of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
* Address reprint requests to Dr Elefteriades, Section of Cardiothoracic Surgery, Yale University School of Medicine, 333 Cedar St, FMB 121, New Haven, CT 06510, USA
e-mail: john.elefteriades{at}yale.edu
Presented at the Thirty-seventh Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 29–31, 2001.
 |
Abstract |
|---|
 Top Abstract IntroductionMaterial and methodsResultsCommentDiscussionReferences |
|---|
Methods. Data on 721 patients (446 male, 275 female; median age, 65.8 years; range, 8 to 95 years) with thoracic aortic disease was prospectively entered into a computerized database over 9 years. Three thousand one hundred fifteen imaging studies were available on these patients. Five hundred seventy met inclusion criteria in terms of length of follow-up and form the basis for the survival analysis. Three hundred four patients were dissection-free at presentation; their natural history was followed for rupture, dissection, and death. Patients were excluded from analysis once operation occurred.
Results. Five-year survival in patients not operated on was 54% at 5 years. Ninety-two hard end points were realized in serial follow-up, including 55 deaths, 13 ruptures, and 24 dissections. Aortic size was a very strong predictor of rupture, dissection, and mortality. For aneurysms greater than 6 cm in diameter, rupture occurred at 3.7% per year, rupture or dissection at 6.9% per year, death at 11.8%, and death, rupture, or dissection at 15.6% per year. At size greater than 6.0 cm, the odds ratio for rupture was increased 27-fold (p = 0.0023). The aorta grew at a mean of 0.10 cm per year. Elective, preemptive surgical repair restored life expectancy to normal.
Conclusions. This study indicates that (1) thoracic aneurysm is a lethal disease; (2) aneurysm size has a profound impact on rupture, dissection, and death; (3) for counseling purposes, the patient with an aneurysm exceeding 6 cm can expect a yearly rate of rupture or dissection of at least 6.9% and a death rate of 11.8%; and (4) elective surgical repair restores survival to near normal. This analysis strongly supports careful radiologic follow-up and elective, preemptive surgical intervention for the otherwise lethal condition of large thoracic aortic aneurysm.
|
Introduction |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsCommentDiscussionReferences |
|---|
Treatment decisions should involve a balancing of the risk of complications caused by the dilated aorta with the risk of complications from the operation itself. The most devastating complications of TAA are dissection, which may lead to arterial occlusion and end-organ ischemia, and rupture, which is almost invariably fatal [1, 2]. Rupture rates in patients not treated surgically are high, ranging from 21% to 74% [1, 3, 4]. However, the risk of operation is also pertinent: elective operation carries a mortality rate of approximately 5% to 9% [4–6]. For emergency operation the mortality rate may be as high as 57% [4, 6]. In addition, the risk of spinal cord injury, particularly in operations on the descending aorta, is significant [7]. Also, stroke occurs with disturbing frequency in operations on both the ascending and descending aortas [8].
A recent MEDLINE search identified nearly 1,000 articles addressing the surgical treatment of TAAs, but less than 10 specifically examining the natural risk of rupture or dissection in aneurysms not treated surgically. In deciding whether or not to operate on the basis of the clinical characteristics of patients there is little hard scientific guidance.
Our group has previously demonstrated that the risk of dissection or rupture increases with aneurysm size [6]. We reported a cumulative, lifetime risk of rupture or dissection by the time specific aortic sizes were reached. Data were not robust enough to permit estimation of yearly risk of rupture or dissection based on size. Juvonen and associates [9] subsequently developed an elegant model using an exponential equation, based on a variety of risk factors, to enable the calculation of rupture risk in specific patients.
The database of the Yale Center for Thoracic Aortic Disease has now grown large enough to permit analyses yielding a simple prediction of yearly rates of rupture or dissection based on aneurysm size for patients with TAA. It is hoped that these data will be of value in decision making for patients being evaluated for surgical extirpation of asymptomatic aortic aneurysms.
|
Material and methods |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsCommentDiscussionReferences |
|---|
Hospital chart review was then conducted on each identified patient, and the data were entered into a computerized database. Data recovered from hospital records and computer files were cross-referenced with hospital discharge abstract data monitored by the Connecticut Hospital Association and the Connecticut State Mortality Records. The database is maintained as part of the ongoing studies at the Yale Center for Thoracic Aortic Disease, a major referral center for southern New England. Patients were recruited and followed between 1985 and 2000.
Inclusion criteria for the subgroup of 304 patients were as follows: aortic size at least 3.5 cm and age older than 6 years at presentation, absence of congenital aortic malformations (for example, aortic coarctation), and at least one size measurement before referral for operative repair. Patients with preexisting dissection were also excluded from analysis because dissection was an end point to this portion of the study. These 304 patients form the basis for the analysis of complication rates. Patient characteristics are shown in Table 1. There were 179 men and 125 women. Median age in this population was 65.8 years and ranged from 8.8 to 93.7 years. Available radiologic follow-up in these patients ranged from 0 to 262 months with a median of 31.6 months. There were 28 patients with Marfan syndrome and no patients identified with other inherited systemic connective tissue diseases.
|
|
The methods of statistical analysis included 
2 test for comparisons of dichotomous risk factors (history of coronary artery disease, congestive heart failure, abdominal aortic aneurysm, and so forth) with negative outcomes (rupture, dissection, death); Mantel-Haenszel 2 test for comparisons taking into consideration disease severity (cardiac disease, pulmonary disease, progressively larger aneurysms, and so forth); and the Wilcoxon test for comparisons of continuous variables with negative outcomes (p < 0.05). Logistic regression analysis of the cumulative incidence was used to evaluate the influence of risk factors for rupture or dissection. Life-table estimates (Kaplan-Meier) were calculated using the LIFETEST procedure of SAS 6.12 for PowerPC (SAS Institute, Cary, NC) with the log-rank test for difference between strata. Average yearly rates were calculated from this life-table analysis using -ln (X)/5 where X is the complication-free survival after 5 years. The Cox regression model (using the PHREG procedure) was used to identify the most predictive variables.
Variables were entered into the models in a forward stepwise manner in the following order: initial aortic size, aneurysm location, age at presentation, and sex, followed by variables indicating a history of hypertension, abdominal aortic aneurysm, tobacco use, coronary artery disease, pulmonary disease, stroke, peripheral vascular disease, congestive heart failure and renal disease, and Marfan disease. Threshold for entry into the model for both logistic regression and Cox regression was p less than 0.10.
Aneurysm growth rates
Of the 304 patients included in the complication analysis, serial imaging (two or more studies) before operative repair was available in 203. An additional 129 patients presenting initially with chronic dissection were able to be included in growth rate analysis. The period of serial radiologic follow-up before operation ranged from 0 to 171.7 months, with a median of 19.1 months. This sample of 332 patients was followed longitudinally and was used to estimate growth rates, and to identify risk factors for higher growth rates. Once patients underwent surgical repair, subsequent measurements were excluded from analysis. Growth rate estimates were obtained by means of a multivariable regression analysis in which aneurysm growth followed an exponential path. In particular, the natural logarithm of the difference between the last measured size and the first measured size was related to the time interval between the two tests and interactions between this time variable and risk factors. This statistical method was previously described in detail by our team [11].
Risk factors analyzed included chronic dissection, initial aneurysm size (stratified into the following groups: less than 4.0 cm, 4 to 4.9 cm, 5 to 5.9 cm, and 6 cm or greater), and aneurysm location (ascending aorta or aortic arch versus descending aorta or thoracoabdominal aorta, and each location separately). Selected additional risk factors were analyzed for their impact on growth, as indicated below.
Complication rates
The incidence of acute dissection or rupture (or both) was evaluated by both descriptive and multivariable analyses. Rupture and dissection were confirmed by at least one of the following: autopsy, operation, death certificate, or computed tomography or magnetic resonance imaging. Patients who underwent surgical treatment were excluded from subsequent analysis.
The multivariable analysis specifies a logistic regression model relating occurrence of rupture or acute dissection to each of the following: initial aortic size (both stratified and unstratified), aneurysm location, age at presentation, sex, Marfan syndrome, cardiac status, hypertension status, pulmonary disease, renal disease, history of smoking, and a history of abdominal aortic aneurysm, coronary artery disease, congestive heart failure, or stroke.
Complication-free survival and long-term survival analysis
Five-year survival estimates were calculated by life-table estimates (Kaplan-Meier). For these analyses, patients were entered into the analysis at the time of initial presentation. For the complication-free survival analysis, patients were censored when they were lost to follow-up, underwent surgical correction, or died without rupture or dissection. Only two major complications, rupture, dissection, or both, were considered in analyzing complication-free survival. For the long-term survival analysis, patients were censored when they were lost to follow-up or underwent surgical correction. Yearly complication rates for subgroups were estimated from the life-table analysis and represent the mean complication rate for each year during the first 5 years after diagnosis.
The specific factors tested for survival differences included initial aortic size (both stratified and unstratified), aneurysm location, age at presentation, sex, Marfan syndrome, cardiac status, hypertension status, pulmonary disease, renal disease, history of smoking, and history of abdominal aortic aneurysm, coronary artery disease, congestive heart failure, or stroke.
|
Results |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsCommentDiscussionReferences |
|---|
Aneurysm growth rates
Aneurysm growth rates were calculated as described earlier. Aneurysms in the descending or thoracoabdominal region had substantially higher growth rates (0.19 cm/y) than those in the ascending aorta or aortic arch (0.07 cm/y). A similar difference in growth rates was found with dissected (0.14 cm/y) versus nondissected (0.09 cm/y) aortas. Patients with Marfan syndrome and those with a history of pulmonary disease also had higher growth rates. Although these were strong trends, the sample sizes were not large enough to demonstrate statistical significance.
Complication rates
Descriptive statistics
Univariate analysis of risk factors predictive of rupture is shown in the top of Table 3.
Initial aortic size of 6.0 cm or greater was associated with nearly a fourfold increase in the incidence of rupture. Other significant univariate predictors of rupture included location of the aneurysm in the descending or thoracoabdominal aorta and a history of abdominal aortic aneurysm. In addition, male sex conferred significant protection from rupture. The analysis in the bottom of Table 3 shows risk factors for dissection. Size showed a strong predictive trend in this analysis. A history of coronary artery disease was associated with a higher incidence of dissection.
|
|
|
|
|
|
|
|
|
|
The yearly rates of complications demonstrate a dramatic increase at sizes greater than 6 cm (Fig 3). This step up in the risk of negative outcomes is clearly evident when rupture, dissection, and death before surgical repair are considered as end points together (Fig 3), with a mean yearly rate more than four times as high in patients with a size of 6 cm or greater than in those with smaller aneurysms.
Long-term survival
Overall long-term survival as a function of initial aortic size is shown in Figure 6.
This figure shows the natural history survival before operation. Five-year survival of patients with aneurysms greater than 6 cm was only 56%. Larger aneurysms are associated with decreased long-term survival (p = 0.0039). Overall, survival for all patients in the database was better for nondissected than for dissected aortas (Fig 7).
Survival was better for the ascending than for the descending aorta (Fig 8).
Figure 9 illustrates the long-term survival after presentation of patients treated medically versus those treated with elective or emergent operation. Elective operation restores a flat survival curve indistinguishable from that of the normal population.
|
|
|
|
|
Comment |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsCommentDiscussionReferences |
|---|
This study confirms that TAA is intrinsically a lethal disease and that aneurysm size has a profound impact on rupture, dissection, and death. We find that the mean rate of rupture or dissection is only 2% per year for small aneurysms, rises to 3% for aneurysms 5.0 to 5.9 cm, and jumps to 6.9% for aneurysms of 6.0 cm in diameter or greater. The risk of rupture alone is near zero for small aneurysms, rises to 1.7% per year for aneurysms 5.0 to 5.9 cm, and jumps to 3.6% per year for aneurysms of 6.0 cm in diameter or greater. The risk of rupture, dissection, or death from all causes is 6.5% at aneurysm size 5.0 to 5.9 cm and jumps to 14.1% per year for aneurysms of 6.0 cm or greater.
Even more striking, when using proportional hazards regression, the odds ratio for rupture indicates that the risk over time of incurring a rupture is more than 25 times higher in patients with aneurysms of 6.0 cm or greater than in those between 4.0 cm and 4.9 cm. Furthermore, even aneurysms in the 5.0-cm to 5.9-cm range are associated with a more than 11 times higher risk of rupture than those in the 4.0-cm to 4.9-cm range.
It is anticipated that these size-specific rates may be of use in counseling individual patients presenting for consideration of elective preemptive surgical extirpation of asymptomatic aneurysms. These data confirm that TAA is a highly lethal condition and support preemptive surgical correction. It is important to emphasize that these data are for asymptomatic aneurysms and that symptomatic aneurysms require extirpation regardless of size. The general thrust of these data suggests intervention before aneurysm size reaches 6.0 cm, consonant with findings and recommendations from our earlier report on a smaller number of patients [6]. Furthermore, these data indicate that aneurysms of smaller size (at least 5.0 cm) may also be associated with a high risk of complications. In fact, size appears to be the primary predictor of rupture.
For individual patients at specific centers, the center’s surgical risk can be factored into the decision making. At our institution, for experienced surgeons, hospital mortality is 2.5% for elective ascending and arch and 10.9% for elective descending and thoracoabdominal aortic operations [8]. This indicates that surgical repair performed electively promises lifetime protection at a mortality cost comparable to, or less than, a single year’s natural rupture or dissection rates. The very flat survival curve (Fig 9) after preemptive surgical repair approaches that of a normal age- and sex-matched population and confirms vividly that surgical repair protects life long-term.
Certain limitations of these data can be enumerated. Definition of rupture, dissection, and aneurysm-related death was strict, as we required in-hospital documentation by imaging studies, surgical findings, or postmortem examination. The true rate of rupture may be higher. The mortality calculations are immune from this factor and represent true rates. Second, patients we followed were operated on electively when they reached size criteria, thus eliminating them from susceptibility to rupture or dissection. The only patients with very large aneurysms followed without operation were those cared for elsewhere before referral to us, those refusing operation, or those believed to be nonsurgical candidates. These two factors—strict definition of aneurysm-related events, and limitation of patients at risk by preemptive operation—imply that the yearly rates we have presented represent minimum lower limits of the actual rates. Some out of hospital deaths were certainly aneurysm-related. Thus, in decision making and counseling, we can presume that the risk of rupture or dissection is at least 6.9% per year for 6-cm or greater aneurysms. On the other hand, the rupture rate cannot exceed the combined end point of 15.6%, as rupture is a lethal event or operatively corrected event.
Two interesting and unanticipated findings of our study are that comorbid vascular disease increased the risk of rupture (odds ratio greater than twofold) and that male sex provides some relative protection (odds ratio, 0.367). This suggests that women require closer scrutiny, possibly because a specific size aneurysm represents proportionately greater aortic dilatation in smaller patients of female sex. Another issue has to do with the influence of concomitant pulmonary disease on aortic events. Multiple prior studies have shown such correlation [9, 14, 15]. We found an adverse impact of pulmonary disease on the rate of growth of the aorta, but did not confirm an impact on rupture or dissection. Regarding hypertension, like the study by Juvonen and coworkers [9], we did not uncover a direct increase in rupture or dissection.
As would be expected, we found increasing size is more strongly associated with an increased risk of rupture, rather than an increased risk of dissection. Dissection may occur at smaller sizes because of other factors (such as connective tissue disease from Marfan syndrome or bicuspid aortic valve), whereas rupture appears to be a predominantly size-related event. This is supported by the fact that when rupture is analyzed alone using logistic regression techniques, size is the only predictor of increasing risk (Table 7); however, when rupture and dissections were analyzed together (Table 5) male sex, a history of stroke, and the presence of Marfan disease all were predictive of higher complication rates.
This review of the natural history of TAAs before surgical repair permits the following conclusions. Thoracic aortic aneurysm is a lethal disease. Forty-six percent of patients with large aneurysms will die within 5 years. Aneurysm size has a profound impact on rupture, dissection, and death. The curves for each adverse event stack higher and higher above each other as aneurysm size increases. For counseling purposes, the patient with an aneurysm exceeding 6 cm in diameter can expect a yearly rate of rupture or dissection of at least 6.9% and a death rate of 15.6% per year. Elective operation eliminates the risk of rupture and restores survival to near normal. Elective surgical repair can be accomplished at a cost of less than a single year’s expected natural mortality. Careful follow-up of patients with TAAs is essential, with preemptive extirpation before the dangerous diameter criterion of 6 cm. It is hoped that these data will permit concrete estimation of the natural history side of the balance of relative risks and benefits of medical management versus surgical intervention for specific patients.
|
Discussion |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsCommentDiscussionReferences |
|---|
Operative intervention in the event of aortic rupture remains a devastating circumstance. Shown here, are the results of 1,611 patients upon whom we have operated for thoracoabdominal aortic aneurysms. Six percent (94 patients) were treated for rupture. The mortality and paraplegia/paraparesis were 17.6% (16 of 94 patients) and 21.2% (20 of 94 patients), clearly clinically significant (p < 0.004, p < 0.007, respectively). This is a slide of a patient with an 11 cm aortic aneurysm upon whom I operated upon last night in Houston for an extent IV thoracoabdominal aortic aneurysm and a contained leak. I am happy to report that she is doing fine.
I would like to ask the authors a few questions. They established, through analysis of their data, that the patients at reasonable risk with aneurysms of 6 cm or greater may be offered operation with less risk than continuing conservative medical management. Would it not be reasonable to operate when the aneurysm measures 5–6 cm as opposed to waiting until 6 cm or greater where the risk is so clearly definitive?
I found it of particular interest that the estimated annual growth rate for patients with pulmonary disease was equal to that of those with Marfan syndrome. I do not believe that this has previously been so clearly established. I would like the authors to comment upon the growth rate of specific size groupings and rate of enlargement with other important variables, such as hypertension, coronary artery disease, and abdominal aortic aneurysm. It is of interest that the authors have pointed out that the history of abdominal aortic aneurysm is a significant variable associated with dissection and rupture. The authors may want to comment upon whether or not this includes previous abdominal aortic aneurysm resection or abdominal aortic aneurysms followed clinically. I might add that our previous work has confirmed an increased incidence of thoracic aortic aneurysms in patients with abdominal aortic aneurysms. This presentation is the first report, of which I am aware, that associates a statistically increased risk of rupture and/or dissection.
I would like to thank the authors for their immense contribution to our knowledge in this field.
DR ELEFTERIADES : Thank you, Dr Coselli. You very appropriately called our attention to the issue of paraplegia as one of the costs of aortic operation. We did not include paraplegia in this discussion because of time. But one way that we look at the decision making for preemptive aortic operation is like refinancing one’s mortgage. By operating on the aneurysm, one decreases the interest rate, or the rate of rupture in the future, but there are up-front closing costs, and the mortality of operation is only one of those up-front closing costs. Paraplegia for descending aneurysms is a very, very important additional closing cost, and we take that heavily into account. The yearly rates presented in this report can be brought down to an individual basis and the risk–benefit ratio calculated for a specific individual patient on the basis of his or her particular aneurysm. Fortunately, for ascending aneurysms, the decisions are easier because paraplegia is not an issue.
Your point about the pulmonary disease is an important one. I was speaking with Dr Griepp yesterday, and his group also found that pulmonary disease correlates with increased adverse aortic events. We were speculating together that we do not know which is the chicken and which is the egg—whether there is a common defect in connective tissues that affects both the lung and the aorta or whether there is something about the pulmonary disease that increases adverse events with the aneurysm.
Regarding the higher incidence of rupture in the setting of prior abdominal aortic aneurysm, we did find an odds ratio for rupture increased fourfold in patients with this history. This may be a marker for general severity of the aortic disease, but the number of patients in this subgroup is quite small, and this finding should be viewed as preliminary.
Your question about when we operate, at what size, is a very important one. We use 5.5 cm as our criterion for the ascending aorta; we use 6.5 cm for the descending, because of the corresponding observed sizes at the time of aortic events. We use a smaller size of 5 cm for the ascending aorta in patients with Marfan or those with a family history. When we take the aortic history in the office, it is impressive how often we get an affirmative response. We inquire, have you had any family members who died prematurely or suddenly or of unexpected cardiac death? The reply is positive very commonly. We consider patients with a family history or a suspected family history to have a connective tissue disorder, and we operate on them earlier, just like our patients with Marfan syndrome. So 5.5 cm is what we use without Marfan syndrome or a family history, and 5.0 cm for the ascending in case of Marfan syndrome or a positive family history.
|
References |
|---|
|
TopAbstractIntroductionMaterial and methodsResultsCommentDiscussionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  H. K. Song, J. E. Bavaria, M. W. Kindem, K. W. Holmes, D. M. Milewicz, C. L. Maslen, R. E. Pyeritz, C. T. Basson, K. Eagle, H. E. Tolunay, et al. Surgical treatment of patients enrolled in the national registry of genetically triggered thoracic aortic conditions. Ann. Thorac. Surg., September 1, 2009; 88(3): 781 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Parish, J. H. Gorman III, S. Kahn, T. Plappert, M. G. St. John-Sutton, J. E. Bavaria, and R. C. Gorman Aortic size in acute type A dissection: implications for preventive ascending aortic replacement Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 941 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. Ramanath, J. K. Oh, T. M. Sundt III, and K. A. Eagle Acute Aortic Syndromes and Thoracic Aortic Aneurysm Mayo Clin. Proc., May 1, 2009; 84(5): 465 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Tadros, M. D. Klein, and O. M. Shapira Ascending Aortic Dilatation Associated With Bicuspid Aortic Valve: Pathophysiology, Molecular Biology, and Clinical Implications Circulation, February 17, 2009; 119(6): 880 - 890. [Full Text] [PDF]
|
|
|
|
 |
|
 G La Canna, F Maisano, L De Michele, A Grimaldi, F Grassi, E Capritti, M De Bonis, and O Alfieri Determinants of the degree of functional aortic regurgitation in patients with anatomically normal aortic valve and ascending thoracic aorta aneurysm. Transoesophageal Doppler echocardiography study Heart, January 15, 2009; 95(2): 130 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Iliopoulos, E. P. Kritharis, A. T. Giagini, S. A. Papadodima, and D. P. Sokolis Ascending thoracic aortic aneurysms are associated with compositional remodeling and vessel stiffening but not weakening in age-matched subjects. J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 101 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Nienaber, I. Akin, R. Erbel, and A. Haverich CHAPTER 31 Diseases of the Aorta and Trauma to the Aorta and the Heart ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]
|
|
|
|
|
|
H. J. Patel and G. M. Deeb Ascending and Arch Aorta: Pathology, Natural History, and Treatment Circulation, July 8, 2008; 118(2): 188 - 195. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lopez, K. L. Arheart, S. D. Colan, N. S. Stein, G. Lopez-Mitnik, A. E. Lin, M. D. Reller, R. Ventura, and M. Silberbach Turner Syndrome Is an Independent Risk Factor for Aortic Dilation in the Young Pediatrics, June 1, 2008; 121(6): e1622 - e1627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Keane and R. E. Pyeritz Medical Management of Marfan Syndrome Circulation, May 27, 2008; 117(21): 2802 - 2813. [Full Text] [PDF]
|
|
|
|
|
|
M. F. Conrad and R. P. Cambria Contemporary Management of Descending Thoracic and Thoracoabdominal Aortic Aneurysms: Endovascular Versus Open Circulation, February 12, 2008; 117(6): 841 - 852. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Masuda, T. Murakami, E. Shishido, and M. Kuinose A Rare Cause of Dissection of Ascending Aorta after Aortic Valve Replacement Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): e4 - e6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Brinster, R. J. Rizzo, and R. M. Bolman III Ascending Aortic Aneurysms Card. Surg. Adult, January 1, 2008; 3(2008): 1223 - 1250. [Full Text]
|
|
|
|
|
|
S. D. Moffatt-Bruce and R. S. Mitchell Endovascular Therapy for the Treatment of Thoracic Aortic Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1299 - 1308. [Full Text]
|
|
|
|
|
|
L. G. Svensson, N. T. Kouchoukos, D. C. Miller, J. E. Bavaria, J. S. Coselli, M. A. Curi, H. Eggebrecht, J. A. Elefteriades, R. Erbel, T. G. Gleason, et al. Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts Ann. Thorac. Surg., January 1, 2008; 85(1_Supplement): S1 - S41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Matura, V. B. Ho, D. R. Rosing, and C. A. Bondy Aortic Dilatation and Dissection in Turner Syndrome Circulation, October 9, 2007; 116(15): 1663 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. Achneck, J. A. Rizzo, M. Tranquilli, and J. A. Elefteriades Safety of Thoracic Aortic Surgery in the Present Era Ann. Thorac. Surg., October 1, 2007; 84(4): 1180 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Pape, T. T. Tsai, E. M. Isselbacher, J. K. Oh, P. T. O'Gara, A. Evangelista, R. Fattori, G. Meinhardt, S. Trimarchi, E. Bossone, et al. Aortic Diameter >=5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD) Circulation, September 4, 2007; 116(10): 1120 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zierer, R. K. Voeller, K. E. Hill, N. T. Kouchoukos, R. J. Damiano Jr, and M. R. Moon Aortic Enlargement and Late Reoperation After Repair of Acute Type A Aortic Dissection Ann. Thorac. Surg., August 1, 2007; 84(2): 479 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. I. Ha, J. B. Seo, S. H. Lee, J.-W. Kang, H. W. Goo, T.-H. Lim, and M. J. Shin Imaging of Marfan Syndrome: Multisystemic Manifestations RadioGraphics, July 1, 2007; 27(4): 989 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kpodonu and E. B. Diethrich Hybrid Interventions for the Treatment of the Complex Aortic Arch Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2007; 19(2): 174 - 184. [Abstract] [PDF]
|
|
|
|
|
|
H. J. Patel, M. S. Shillingford, D. M. Williams, G. R. Upchurch Jr, N. L. Dasika, R. L. Prager, and G. M. Deeb Survival Benefit of Endovascular Descending Thoracic Aortic Repair for the High-Risk Patient Ann. Thorac. Surg., May 1, 2007; 83(5): 1628 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Davies, R. K. Kaple, D. Mandapati, A. Gallo, D. M. Botta Jr, J. A. Elefteriades, and M. A. Coady Natural History of Ascending Aortic Aneurysms in the Setting of an Unreplaced Bicuspid Aortic Valve Ann. Thorac. Surg., April 1, 2007; 83(4): 1338 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Bavaria, J. J. Appoo, M. S. Makaroun, J. Verter, Z.-F. Yu, R. S. Mitchell, and Gore TAG Investigators Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: A multicenter comparative trial J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 369 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur. Heart J., January 26, 2007; (2007) ehl428v1. [Full Text] [PDF]
|
|
|
|
|
|
G. Albornoz, M. A. Coady, M. Roberts, R. R. Davies, M. Tranquilli, J. A. Rizzo, and J. A. Elefteriades Familial thoracic aortic aneurysms and dissections-incidence, modes of inheritance, and phenotypic patterns. Ann. Thorac. Surg., October 1, 2006; 82(4): 1400 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Nataf and E Lansac Dilation of the thoracic aorta: medical and surgical management. Heart, September 1, 2006; 92(9): 1345 - 1352. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF]
|
|
|
|
|
|
A. Zierer, S. J. Melby, J. G. Lubahn, G. A. Sicard, R. J. Damiano Jr, and M. R. Moon Elective Surgery for Thoracic Aortic Aneurysms: Late Functional Status and Quality of Life Ann. Thorac. Surg., August 1, 2006; 82(2): 573 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Maurer Aortic regurgitation. Heart, July 1, 2006; 92(7): 994 - 1000. [Full Text] [PDF]
|
|
|
|
|
|
R. R. Davies, A. Gallo, M. A. Coady, G. Tellides, D. M. Botta, B. Burke, M. P. Coe, G. S. Kopf, and J. A. Elefteriades Novel Measurement of Relative Aortic Size Predicts Rupture of Thoracic Aortic Aneurysms Ann. Thorac. Surg., January 1, 2006; 81(1): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Neri, L. Barabesi, D. Buklas, L. A. Vricella, A. Benvenuti, E. Tucci, C. Sassi, and M. Massetti Limited role of aortic size in the genesis of acute type A aortic dissection Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 857 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Castelli, R. Caronno, G. Piffaretti, M. Tozzi, C. Lomazzi, D. Lagana, G. Carrafiello, and S. Cuffari Endovascular repair for concomitant multilevel aortic disease Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 478 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Koullias, R. Modak, M. Tranquilli, D. P. Korkolis, P. Barash, and J. A. Elefteriades Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 677 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. T. Hassoun, M. D. Dake, L. G. Svensson, R. K. Greenberg, R. P. Cambria, R. D. Moore, and J. S. Matsumura Multi-institutional Pivotal Trial of the Zenith TX2 Thoracic Aortic Stent-Graft for Treatment of Descending Thoracic Aortic Aneurysms: Clinical Study Design Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2005; 17(3): 255 - 264. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Elefteriades, M. Tranquilli, U. Darr, J. Cardon, B-Q Zhu, and P. Barrett Symptoms Plus Family History Trump Size in Thoracic Aortic Aneurysm Ann. Thorac. Surg., September 1, 2005; 80(3): 1098 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Milewicz, H. C. Dietz, and D. C. Miller Treatment of Aortic Disease in Patients With Marfan Syndrome Circulation, March 22, 2005; 111(11): e150 - e157. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Isselbacher Thoracic and Abdominal Aortic Aneurysms Circulation, February 15, 2005; 111(6): 816 - 828. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Enriquez-Sarano and A. J. Tajik Aortic Regurgitation N. Engl. J. Med., October 7, 2004; 351(15): 1539 - 1546. [Full Text] [PDF]
|
|
|
|
|
|
P. Demers, D. C. Miller, R. S. Mitchell, S. T. Kee, D. Sze, M. K. Razavi, and M. D. Dake Midterm results of endovascular repair of descending thoracic aortic aneurysms with first-generation stent grafts J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 664 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hopkins Aortic valve leaflet sparing and salvage surgery: evolution of techniques for aortic root reconstruction Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 886 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ueda, H. Shimizu, K. Hashizume, K. Koizumi, M. Mori, H. Shin, and R. Yozu Mortality and morbidity after total arch replacement using a branched arch graft with selective antegrade cerebral perfusion Ann. Thorac. Surg., December 1, 2003; 76(6): 1951 - 1956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Okamoto, H. Xu, N. T. Kouchoukos, M. R. Moon, and T. M. Sundt III The influence of mechanical properties on wall stress and distensibility of the dilated ascending aorta J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 842 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Moffatt and R. S. Mitchell Endovascular Stent Management of Thoracic Aneurysms and Dissections Card. Surg. Adult, January 1, 2003; 2(2003): 1191 - 1204. [Full Text]
|
|
|
|
|
|
J. A. Elefteriades Invited commentary Ann. Thorac. Surg., March 1, 2002; 73(3): 743 - 744. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
